Karine Perlemoine
About
Karine Perlemoine is a scholar working on Surgery, Cancer Research and Cardiology and Cardiovascular Medicine.
According to data from OpenAlex, Karine Perlemoine has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 15 papers in Cancer Research and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Karine Perlemoine's work include Adrenal and Paraganglionic Tumors (15 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Cardiac tumors and thrombi (11 papers). Karine Perlemoine is often cited by papers focused on Adrenal and Paraganglionic Tumors (15 papers), Cancer, Hypoxia, and Metabolism (14 papers) and Cardiac tumors and thrombi (11 papers). Karine Perlemoine collaborates with scholars based in France, United States and Morocco. Karine Perlemoine's co-authors include Jérôme Bertherat, Xavier Bertagna, Lionel Groussin, Eric Jullian, Frédérique Tissier, Fernande René-Corail, Christine Gicquel, J P Luton, Constantine A. Stratakis and Bruno Ragazzon and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cancer Research.
In The Last Decade
Karine Perlemoine
28 papers receiving 1.7k citations
Peers
Karine Perlemoine
Fernande René-Corail France
Bruno Ragazzon France
Ludmila Matyakhina United States
Laure Cazabat France
Sosipatros A. Boikos United States
Paul A. Crossey United Kingdom
Paraskevi Xekouki United States
Diana E. Benn Australia
Euy Young Soh South Korea
Citations per year, relative to Karine Perlemoine Karine Perlemoine (= 1×)
peers
Fernande René-Corail
Countries citing papers authored by Karine Perlemoine
Since
Specialization
Citations
This map shows the geographic impact of Karine Perlemoine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Perlemoine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Perlemoine more than expected).
Fields of papers citing papers by Karine Perlemoine
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Karine Perlemoine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Perlemoine. The network helps show where Karine Perlemoine may publish in the future.
Co-authorship network of co-authors of Karine Perlemoine
This figure shows the co-authorship network connecting the top 25 collaborators of Karine Perlemoine. A scholar is included among the top collaborators of Karine Perlemoine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Perlemoine. Karine Perlemoine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bioletto, Fabio, Karine Perlemoine, Fidéline Bonnet-Serrano, et al.. (2025). Transcriptomic classification of prolactinomas and somatotropinomas identifies subtypes with variable resistance to treatment. European Journal of Endocrinology. 193(4). 474–486.
2.
Cormier, Françoise, Florent Dumont, Béatrix Cochand‐Priollet, et al.. (2023). NF-κB signaling activation and roles in thyroid cancers: implication of MAP3K14/NIK. Oncogenesis. 12(1). 55–55.
3.
Bouys, Lucas, Annabel Berthon, Bruno Ragazzon, et al.. (2023). Impact of Morphology in the Genotype and Phenotype Correlation of Bilateral Macronodular Adrenocortical Disease (BMAD): A Series of Clinicopathologically Well-Characterized 35 Cases. Endocrine Pathology. 34(2). 179–199.
4.
Buffet, Camille, Laïla El Khattabi, Marthe Rizk‐Rabin, et al.. (2019). MET overexpression and activation favors invasiveness in a model of anaplastic thyroid cancer. Oncotarget. 10(23). 2320–2334.
5.
Fonseca, Fernando, et al.. (2017). ARMC5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (PBMAH). Endocrinology Diabetes and Metabolism Case Reports. 2017.
6.
Lefèvre, Lise, H. Omeiri, Ludivine Drougat, et al.. (2015). Combined transcriptome studies identify AFF3 as a mediator of the oncogenic effects of β-catenin in adrenocortical carcinoma. Oncogenesis. 4(7). e161–e161.
7.
Ragazzon, Bruno, Rossella Libé, Guillaume Assié, et al.. (2013). Mass-array screening of frequent mutations in cancers reveals RB1 alterations in aggressive adrenocortical carcinomas. European Journal of Endocrinology. 170(3). 385–391.
8.
Gaujoux, Sébastien, Constanze Hantel, Pierre Launay, et al.. (2013). Silencing Mutated β-Catenin Inhibits Cell Proliferation and Stimulates Apoptosis in the Adrenocortical Cancer Cell Line H295R. PLoS ONE. 8(2). e55743–e55743.
9.
Barreau, Olivia, Guillaume Assié, Bruno Ragazzon, et al.. (2012). Identification of a CpG Island Methylator Phenotype in Adrenocortical Carcinomas. The Journal of Clinical Endocrinology & Metabolism. 98(1). E174–E184.
10.
Gaujoux, Sébastien, Frédérique Tissier, Bruno Ragazzon, et al.. (2011). Pancreatic Ductal and Acinar Cell Neoplasms in Carney Complex: A Possible New Association. The Journal of Clinical Endocrinology & Metabolism. 96(11). E1888–E1895.
11.
Libé, Rossella, Anélia Horvath, Delphine Vezzosi, et al.. (2010). Frequent Phosphodiesterase 11A Gene (PDE11A) Defects in Patients with Carney Complex (CNC) Caused byPRKAR1AMutations:PDE11AMay Contribute to Adrenal and Testicular Tumors in CNC as a Modifier of the Phenotype. The Journal of Clinical Endocrinology & Metabolism. 96(1). E208–E214.
12.
Ragazzon, Bruno, Laure Cazabat, Marthe Rizk‐Rabin, et al.. (2009). Inactivation of the Carney Complex Gene 1 ( Protein Kinase A Regulatory Subunit 1A ) Inhibits SMAD3 Expression and TGFβ-Stimulated Apoptosis in Adrenocortical Cells. Cancer Research. 69(18). 7278–7284.
13.
Bossis, Ioannis, Laure Cazabat, Manos Mavrakis, et al.. (2008). Protein Kinase A Effects of an Expressed PRKAR1A Mutation Associated with Aggressive Tumors. Cancer Research. 68(9). 3133–3141.
14.
Vincent-Dejean, Caroline, Laure Cazabat, Lionel Groussin, et al.. (2008). Identification of a clinically homogenous subgroup of benign cortisol-secreting adrenocortical tumors characterized by alterations of the protein kinase A (PKA) subunits and high PKA activity.. European Journal of Endocrinology. 158(6). 829–839.
15.
Cazabat, Laure, Rossella Libé, Karine Perlemoine, et al.. (2007). Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas. European Journal of Endocrinology. 157(1). 1–8.
16.
Rosenberg, Dan, Lionel Groussin, Eric Jullian, et al.. (2003). Transcription Factor 3′,5′-Cyclic Adenosine 5′-Monophosphate-Responsive Element-Binding Protein (CREB) Is Decreased during Human Adrenal Cortex Tumorigenesis and Fetal Development. The Journal of Clinical Endocrinology & Metabolism. 88(8). 3958–3965.
17.
Rosenberg, Dan, Lionel Groussin, Eric Jullian, et al.. (2002). Role of the PKA‐Regulated Transcription Factor CREB in Development and Tumorigenesis of Endocrine Tissues. Annals of the New York Academy of Sciences. 968(1). 65–74.
18.
Groussin, Lionel, Karine Perlemoine, Vincent Contesse, et al.. (2002). The Ectopic Expression of the Gastric Inhibitory Polypeptide Receptor Is Frequent in Adrenocorticotropin-Independent Bilateral Macronodular Adrenal Hyperplasia, but Rare in Unilateral Tumors. The Journal of Clinical Endocrinology & Metabolism. 87(5). 1980–1985.
19.
Groussin, Lionel, Lawrence S. Kirschner, Caroline Vincent-Dejean, et al.. (2002). Molecular Analysis of the Cyclic AMP-Dependent Protein Kinase A (PKA) Regulatory Subunit 1A (PRKAR1A) Gene in Patients with Carney Complex and Primary Pigmented Nodular Adrenocortical Disease (PPNAD) Reveals Novel Mutations and Clues For Pathophysiology: Augmented PKA Signaling is Associated with Adrenal Tumorigenesis in PPNAD. The American Journal of Human Genetics. 71(6). 1433–1442.
20.
Groussin, Lionel, Eric Jullian, Karine Perlemoine, et al.. (2002). Mutations of thePRKAR1AGene in Cushing’s Syndrome due to Sporadic Primary Pigmented Nodular Adrenocortical Disease. The Journal of Clinical Endocrinology & Metabolism. 87(9). 4324–4329.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Fernande René-Corail Breakdown of academic impact, for papers by Bruno Ragazzon Breakdown of academic impact, for papers by Ludmila Matyakhina Breakdown of academic impact, for papers by Laure Cazabat Breakdown of academic impact, for papers by Sosipatros A. Boikos Breakdown of academic impact, for papers by Maria Candida Barisson Villares Fragoso Breakdown of academic impact, for papers by Paul A. Crossey Breakdown of academic impact, for papers by Paraskevi Xekouki Breakdown of academic impact, for papers by Diana E. Benn Breakdown of academic impact, for papers by Euy Young Soh